Clinical Trial Update: Iressa Case Control Study in Japan

View source ↗

Summary

A completed case-control study in Japan evaluating Iressa (gefitinib) for non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Non-small Cell Lung Cancer | Status: COMPLETED